Uric acid lowering in relation to HbA1c reductions with the SGLT2 inhibitor tofogliflozin

Sodium–glucose cotransporter 2 inhibition and cardiovascular risk reduction in patients with type 2 diabetes: the emerging role of natriuresis

(2016) Harindra Rajasekeran et al.   KIDNEY INTERNATIONAL

A novel and selective sodium-glucose cotransporter-2 inhibitor, tofogliflozin, improves glycaemic control and lowers body weight in patients with type 2 diabetes mellitus

(2015) S. Ikeda et al.   DIABETES OBESITY & METABOLISM

Effect of canagliflozin on serum uric acid in patients with type 2 diabetes mellitus

(2015) M. J. Davies et al.   DIABETES OBESITY & METABOLISM

Efficacy and safety of monotherapy with the novel sodium/glucose cotransporter-2 inhibitor tofogliflozin in Japanese patients with type 2 diabetes mellitus: a combined Phase 2 and 3 randomized, placebo-controlled, double-blind, parallel-group comparative study

(2014) Kohei Kaku et al.   Cardiovascular Diabetology

Long-term safety and efficacy of tofogliflozin, a selective inhibitor of sodium-glucose cotransporter 2, as monotherapy or in combination with other oral antidiabetic agents in Japanese patients with type 2 diabetes mellitus: multicenter, open-label, randomized controlled trials

(2014) Yukio Tanizawa et al.   EXPERT OPINION ON PHARMACOTHERAPY

Change in urinary N-acetyl-β-d-glucosaminidase levels relevant to postprandial glycemic control conditions in subjects without diabetes mellitus

(2013) Motoshi Ouchi et al.   CLINICA CHIMICA ACTA

Serum uric acid in relation to serum 1,5-anhydroglucitol levels in patients with and without type 2 diabetes mellitus

(2013) Motoshi Ouchi et al.   CLINICAL BIOCHEMISTRY

Postprandial Glycemic Control Conditions in Relation to Urinary N-Acetyl-β-d-Glucosaminidase in Patients with Type 2 Diabetes Mellitus Without Low Glomerular Filtration Rate

(2013) Motoshi Ouchi et al.   Diabetes Technology & Therapeutics

Effect of canagliflozin, a sodium-glucose cotransporter 2 inhibitor, on measurement of serum 1,5-anhydroglucitol (坎格列净，一种钠-葡萄糖共转运体2抑制剂，对血清1,5-脱水葡萄糖醇测定的影响)

(2013) Dainius A. Balis et al.   Journal of Diabetes

Close relationship between serum concentrations of 1,5-anhydroglucitol and uric acid in non-diabetic male subjects implies common renal transport system

(2009) M. Koga et al.   CLINICA CHIMICA ACTA

Haemoglobin A1c, fasting glucose, serum C-peptide and insulin resistance in relation to serum uric acid levels--the Third National Health and Nutrition Examination Survey

(2008) H. K. Choi et al.   RHEUMATOLOGY